肺炎支原体感染后咳嗽采取布地奈德雾化吸入治疗的疗效分析

Curative Effect of Budesonide Atomization Inhalation for Coughing after Mycoplasma Pneumoniae Infection

目的:分析肺炎支原体感染后咳嗽采取布地奈德雾化吸入治疗的疗效。方法:随机选择2015年2月~2017年2月在某院接受治疗的肺炎支原体感染后咳嗽患者120例参与研究,按照患者入院的先后顺序一对一分组,参照组60例患者行常规治疗,研究组60例患者行布地奈德雾化吸入治疗,比较两组治疗效果。结果:研究组患者临床疗效、咳嗽症状评分、住院时间、咳嗽消失时间均明显优于参照组(P<0.05)。结论:对肺炎支原体感染后咳嗽患者实施布地奈德雾化吸入治疗,能够显著改善患者症状,临床价值显著。

Objective：To analyze the curative effect of budesonide atomization inhalation for coughing af- ter mycoplasma pneumoniae infection.Methods： 120 cases patients with coughing after mycoplasma pneumoniae infection treated in a hospital from February＇2015 to February 2017 were randomly selected and divided into control group and study group according to the order of admission,with 60 cases in each group.The con- trol group was given routine therapy,and the study group was given budesonide atomization inhalation treatment,then the therapeutic effects of two groups were compared. Results： The clinical curative effect, cough symptom score, hospitalization time and coughing disappearance time of the study group were obviously su- perior to those of the control group （P〈0.05）.Conclusion： The treatment of budesonide inhalation for patients with mycoplasma pneumoniae infected cough can significantly improve the symptoms of the patients, with significant clinical value.